By Armen Hareyan on January 13, 2006 - 9:15am 
for eMaxHealth
for eMaxHealthOvarian Cancer
Women with ovarian cancer are more likely in 2006 to receive a treatment that will significantly extend their lives, said Nelson Teng, MD, director of gynecological oncology.
Until last week the standard treatment for ovarian cancer involved intravenous chemotherapy. On Jan. 5 results of a major trial were published in the New England Journal of Medicine showing that women who received additional chemotherapy pumped directly into their abdominal cavity lived on average 16 months longer than women who got the standard care.
"Sixteen months is the biggest improvement in lifespan we have
Source:
Stanford University eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.
